Sagility Ltd (SAGILITY) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sagility Ltd on NSE and BSE, with an AI summary of each filing.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 02, 2026 for Sagility BV
Encumbered Shares - Invocation / Release · 03 Nov 2026, 4:15 pm
Sagility B.V. Trims Sagility Limited Stake via 11.96% Bulk Deal Promoter Sagility B.V. sold 560,000,000 equity shares (11.96% stake) of Sagility Limited via an on-market bulk deal settled on 2nd Nov'26. The transaction reduces Sagility B.V.'s holding and total indirectly encumbered shares from 2,385,129,151 equity shares (50.95%) to 1,825,129,151 equity shares (38.99%) on a fully diluted basis. The disposal triggers an indirect release of encumbrances tied to borrowing arrangements with Global Loan Agency Services Australia Nominees Pty Ltd (CPPIB Credit Investments) and HSBC-led lending syndicates.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sagility B.V.
Acquisition/ Disposal of Shares · 03 Nov 2026, 4:13 pm
Promoter Sagility B.V. Sells 11.96% Stake in Sagility Limited Promoter Sagility B.V. sold 56,00,00,000 equity shares, representing an 11.96% stake in Sagility Limited, via open market transactions on 2nd Nov'26. Following the disposal, the promoter's holding decreased from 2,38,51,29,151 shares (50.95% voting capital) to 1,82,51,29,151 shares (38.99% voting capital). The total equity share capital of the company remained unchanged post-sale at 4,68,13,28,413 shares (face value ₹10 each), aggregating to ₹46,79,27,43,610.
Transcript of Earnings Call held on October 22, 2026
Transcript · 29 Oct 2026, 3:31 pm
Communication to Shareholders regarding TDS on Interim Dividend FY2026-27
Dividend · 23 Oct 2026, 11:49 pm
Sagility Limited Announces Interim Dividend and TDS Guidelines for FY 2026-27 Sagility Limited declared an interim dividend of Rs. 0.15 per equity share (face value Rs. 10) for FY 2026-27, with the record date set for 30th Oct'26. The company outlined TDS provisions: 10% for resident shareholders with valid PAN (exempt if annual dividend does not exceed Rs. 10,000 or upon Form 121 submission), 20% for invalid or unlinked PAN-Aadhaar, and 20% or lower DTAA rates for non-residents. Relevant tax exemption forms must be submitted to the RTA by 3rd Nov'26.
Disclosure of Investor Call Recording Q2FY27
Audio / Video · 23 Oct 2026, 1:51 pm
Sagility Limited Releases Investor Webinar Recording for Q2 FY27 Financial Results Sagility Limited has made available the video recording of its investor and analyst webinar held on 22nd Oct'26 at 7:30 p.m. IST. The session covered the company's unaudited financial results for the second quarter and half-year ended 30th Sep'26. Pursuant to SEBI Listing Regulations, the recording has been uploaded and can be accessed directly via the investor relations section on the company's official website.
Board approves Interim dividend for FY 2026-27
Dividend · 23 Oct 2026, 12:25 am
Sagility Declares Interim Dividend of ₹0.15 per Share for FY27 The Board of Directors of Sagility Limited has declared an interim dividend of ₹0.15 per equity share of face value ₹10 each for FY26-27 at its meeting on 22nd Oct'26. The record date to determine eligible shareholders is set for 30th Oct'26. The declared interim dividend will be disbursed on or before 21st Nov'26.
Corporate Action - Record date intimation for Interim dividend FY 2026-27
Dividend · 23 Oct 2026, 12:21 am
Sagility Limited Declares FY27 Interim Dividend of Rs 0.15 Per Share The Board of Directors of Sagility Limited declared an interim dividend of Rs 0.15 per equity share (face value Rs 10 each) for FY26-27 at its meeting on 22nd Oct'26. The record date for determining shareholder eligibility is fixed for 30th Oct'26. The dividend payout is scheduled to be completed on or before 21st Nov'26.
Corporate Action - Board approves Interim dividend for FY 2026-27
Dividend · 23 Oct 2026, 12:16 am
Sagility Limited Declares Interim Dividend of ₹0.15 Per Share for FY27 The Board of Directors of Sagility Limited declared an interim dividend of ₹0.15 per equity share of face value ₹10 each for FY27. The record date to determine eligible shareholders is set for 30th Oct'26. The company will complete the dividend payment on or before 21st Nov'26.
Press release pertaining to unaudited financial results (standalone & consolidated) for the quarter ended September 30, 2026
Press Release · 23 Oct 2026, 12:12 am
Sagility Reports Strong Q2 FY27 Results with 22.5% YoY Revenue Growth Sagility Limited reported Q2 FY27 consolidated revenue of ₹20,321 million ($212.6 million), up 22.5% YoY (12.2% in constant currency), with organic growth at 22.2%. Adjusted EBITDA rose 23.0% YoY to ₹5,353 million, delivering a 26.3% margin. Adjusted PAT reached ₹3,254 million, up 8.1% YoY, while reported PAT expanded 13.3% to ₹2,842 million. The company secured $40.2 million in ACV, acquired Chirok Health LLC to strengthen provider RCM capabilities, and declared an interim dividend of ₹0.15 per share for the quarter ended 30th Sep'26.
SAGILITY LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 23 Oct 2026, 12:07 am
Sagility Limited Reports Strong Q2 FY27 Results and Chirok Health Acquisition Sagility Limited posted a 22.5% YoY rise in Q2 FY27 consolidated revenue from operations to ₹20,321 million (12.2% constant currency growth). Adjusted EBITDA rose 23.0% YoY to ₹5,353 million with margins at 26.3%, while consolidated PAT grew 13.3% YoY to ₹2,842.12 million. The company secured $40.2 million in ACV and approved an interim dividend of ₹0.15 per share (record date 30th Oct'26). Additionally, Sagility signed a definitive agreement on 21st Oct'26 to acquire US-based Chirok Health LLC for up to $32.35 million.
Financial Results for quarter ended September 30, 2026
Financial Result · 23 Oct 2026, 12:05 am
Sagility Reports Strong Q2 FY27 Results and Chirok Health Acquisition Sagility Limited delivered solid Q2 FY27 consolidated revenue of ₹20,321 million, up 22.5% YoY (12.2% CC), driven by 24.4% growth in its Payer vertical. Adjusted EBITDA increased 23.0% YoY to ₹5,353 million with margins expanding to 26.3%, while reported PAT grew 13.3% YoY to ₹2,842.12 million. The company declared an interim dividend of ₹0.15 per share. In a key strategic move, Sagility signed a definitive agreement to acquire US-based Chirok Health LLC for up to US$32.35 million, bolstering its provider RCM and clinical documentation capabilities.
Investor presentation to be made on October 22, 2026
Investor Presentation · 22 Oct 2026, 11:58 pm
Sagility Reports Strong Q2 FY27 Financial Growth and Acquires Chirok Health Sagility delivered solid Q2 FY27 performance with revenue growing 22.5% YoY (12.2% CC) to ₹20,321M ($212.6M). Adjusted EBITDA increased 23.0% YoY to ₹5,353M, expanding margins to 26.3%, while Adjusted PAT rose 8.1% YoY to ₹3,254M. The company secured $40.2M in ACV and announced an interim dividend of ₹0.15 per share. Total debt is on track to be fully repaid in FY27. Additionally, Sagility acquired Chirok Health for $20M upfront plus up to $12.35M contingent consideration to boost Provider segment RCM and CDI capabilities.
SAGILITY LIMITED has informed the Exchange regarding Outcome of Board Meeting held on October 22, 2026.
Outcome · 22 Oct 2026, 11:55 pm
Sagility Delivers Strong Q2 FY27 Results; Approves Interim Dividend and Chirok Health Acquisition Sagility Limited reported consolidated Q2 FY27 revenue growth of 22.5% YoY (12.2% in constant currency) to ₹20,321 million, driven by a 24.4% YoY rise in its Payer vertical. Adjusted EBITDA increased 23.0% YoY to ₹5,353 million with margins at 26.3%, while reported PAT reached ₹2,842.12 million (up 13.3% YoY). The company agreed to acquire US-based Chirok Health for $32.35 million to boost provider RCM capabilities and declared an interim dividend of ₹0.15 per share (record date 30th Oct'26).
Outcome of Board Meeting held on October 22, 2026
Outcome · 22 Oct 2026, 11:53 pm
Sagility Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 20,321 (+22.5% YoY | +3.5% QoQ) ■ EBIT: 3,799 (+29.4% YoY | +22.5% QoQ) ■ EBIT Margin (%): 18.7 (+99 bps YoY | +290 bps QoQ) ■ PAT: 2,842 (+13.3% YoY | +31.1% QoQ) ■ EPS (INR): 0.61 (+15.1% YoY | +32.6% QoQ)
Sagility accelerates provider growth strategy through Acquisition of Chirok Health
Press Release · 22 Oct 2026, 2:53 am
Sagility Acquires Chirok Health to Bolster Provider Services Platform On 21st Oct'26, Sagility announced the acquisition of Chirok Health to accelerate its provider-focused growth strategy. Chirok adds specialized mid-revenue cycle capabilities, including Clinical Documentation Improvement (CDI), medical coding, coding quality assurance, and revenue integrity, complementing Sagility's existing front- and back-end offerings. Alongside the recent CareSeed acquisition, the deal enhances Sagility’s value-based care and risk adjustment offerings, integrates specialized clinical talent, and unlocks cross-selling opportunities across client bases by pairing Chirok’s domain expertise with Sagility's AI, automation, and analytics capabilities.
Sagility accelerates provider growth strategy through Acquisition of Chirok Health
Others (Uncategorized) · 22 Oct 2026, 2:46 am
Sagility to Acquire Chirok Health for up to $32.35M Sagility Limited's wholly owned subsidiary, Sagility (US) Holdings Inc., signed a definitive agreement on 21st Oct'26 to acquire a 100% stake in US-based Chirok Health LLC for an aggregate cash consideration of up to $32.35M. The deal includes an upfront payment of $20.0M and milestone-based contingent payouts of up to $12.35M. Chirok Health, an RCM and clinical documentation integrity specialist with CY25 turnover of $9.0M, expands Sagility's provider capabilities through its proprietary CHEMP workflow platform.
Sagility Limited has informed the Exchange about Board Meeting to be held on 22-Oct-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Dividend.
Intimation · 22 Oct 2026, 5:30 am
Intimation of Investor Call to be held on 22/10/2026
Intimation · 22 Oct 2026, 7:30 pm
Sagility Limited Schedules Q2 FY27 Earnings Webinar on 22nd Oct'26 Sagility Limited will host an earnings webinar for analysts and investors on 22nd Oct'26 at 7:30 PM IST to discuss its unaudited operational and financial results for the quarter and half-year ended 30th Sep'26. The management will be represented by Managing Director and Group CEO Ramesh Gopalan alongside Group CFO Srinivas Rathnam Mattapalli. The session will cover business commentary and financial performance, followed by an interactive Q&A. Pre-registration via Zoom is mandatory up to three hours prior to the call.
To consider and approve the financial results for the period ended September 30, 2026 and interim dividend, if any, for FY2026-27
Intimation · 22 Oct 2026, 5:30 am
Sagility Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....
Intimation · 22 Oct 2026, 5:30 am
Sagility Limited Board to Consider Q2 FY27 Results and Interim Dividend Sagility Limited's Board of Directors will meet on 22nd Oct'26 to review and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The board will also consider a proposal for declaring an interim dividend for FY 2026-27. In compliance with insider trading regulations, the trading window for dealing in company securities remains closed from 1st Oct'26 until 24th Oct'26 (inclusive).
Change in management
Change in Management · 02 Oct 2026, 4:42 am
Sagility Appoints Brian Clayton as Global General Counsel Sagility Limited announced the resignation of Daniel B. Bailey from his position as Global General Counsel and Senior Management Personnel, effective 2nd Oct'26, citing personal reasons. To succeed him, the Board of Directors approved the appointment of Brian Clayton as Global General Counsel and Senior Management Personnel, effective 2nd Oct'26. Clayton brings over two decades of global legal and compliance experience, having previously held senior leadership roles at Omnicom Group and Conduent across healthcare, technology, and business services sectors.
Communication to Shareholders relating to payment of Final Dividend FY2025-26
Dividend · 25 Sept 2026, 10:04 pm
Sagility Limited Issues Shareholder Communication on FY26 Final Dividend Payment Sagility Limited announced on 25th Sep'26 that final dividend payments for FY25-26 have been processed for shareholders with updated bank records. The company declared a final dividend of Rs. 0.10 per equity share (face value Rs. 10 each) at its AGM held on 20th Aug'26, following the record date of 7th Aug'26. Shareholders with missing or invalid bank details have been dispatched notices to update KYC and banking information via their Depository Participants to enable electronic credit, as physical warrants remain discontinued per SEBI regulations.
Intimation of investor meet pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation · 15 Sept 2026, 8:53 pm
Sagility Limited to Attend 2026 Jefferies India Forum Sagility Limited announced that company officials will attend the 2026 Jefferies India Forum on 18th Sep'26 at The Oberoi, Gurgaon. The event involves group meetings with multiple investors. Management will discuss industry and company developments already in the public domain, ensuring no unpublished price-sensitive information is shared.
Re-appointment of Mr. Hari Gopalakrishnan (DIN: 03289463) retiring by rotation at the 5th Annual General Meeting
Annual General Meeting · 21 Aug 2026, 11:45 pm
Voting Results and Scrutinizer''s Report of 5th Annual General Meeting
Annual General Meeting · 21 Aug 2026, 11:31 pm